LTFS
ICPT

Ladenburg Thalmann Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$8.75M Buy
70,605
+383
+0.5% +$34.3K 0.06% 332
2019
Q3 		$4.66M Buy
70,222
+68,123
+3,245% +$4.57M 0.03% 486
2019
Q2 		$168K Sell
2,099
-859
-29% -$76.9K ﹤0.01% 2590
2019
Q1 		$331K Buy
2,958
+603
+26% +$65.9K ﹤0.01% 2008
2018
Q4 		$236K Sell
2,355
-5,244
-69% -$544K ﹤0.01% 2113
2018
Q3 		$961K Sell
7,599
-8,823
-54% -$934K 0.01% 1141
2018
Q2 		$1.01M Hold
16,422
– – 0.01% 1066
2018
Q1 		$1.01M Buy
16,422
+10,007
+156% +$603K 0.01% 1066
2017
Q4 		$375K Sell
6,415
-1,167
-15% -$73.6K ﹤0.01% 1748
2017
Q3 		$440K Buy
7,582
+5,648
+292% +$608K ﹤0.01% 1553
2017
Q2 		$234K Buy
1,934
+400
+26% +$46.3K ﹤0.01% 1905
2017
Q1 		$173K Sell
1,534
-96
-6% -$11.2K ﹤0.01% 2022
2016
Q4 		$178K Buy
1,630
+462
+40% +$55K ﹤0.01% 1898
2016
Q3 		$193K Buy
1,168
+12
+1% +$1.89K ﹤0.01% 1786
2016
Q2 		$165K Buy
1,156
+352
+44% +$51.3K ﹤0.01% 1806
2016
Q1 		$103K Buy
804
+1
+0.1% +$118 ﹤0.01% 2045
2015
Q4 		$120K Buy
803
+19
+2% +$3.22K ﹤0.01% 1930
2015
Q3 		$130K Buy
784
+102
+15% +$22.4K ﹤0.01% 1799
2015
Q2 		$165K Sell
682
-60
-8% -$16K ﹤0.01% 1743
2015
Q1 		$209K Buy
742
+60
+9% +$13K ﹤0.01% 1546
2014
Q4 		$106K Sell
682
-125
-15% -$23.1K ﹤0.01% 1855
2014
Q3 		$191K Buy
807
+276
+52% +$70.4K 0.01% 1237
2014
Q2 		$126K Buy
531
+431
+431% +$114K ﹤0.01% 1459
2014
Q1 		$33K Buy
+100
New +$33.7K ﹤0.01% 2239

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ICPT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 0.55% in Q4 2019, buying an estimated $34.3K and bringing the position to 70,605 shares worth $8.75M. The position accounts for 0.06% of the portfolio, ranked #332.

Ladenburg Thalmann Financial Services first reported a position in ICPT in Q1 2014 and has held it in 24 quarters since. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 70,605 shares of Intercept Pharmaceuticals, Inc. worth $8.75M as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 383 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $34.3K.
  • Intercept Pharmaceuticals, Inc. made up 0.06% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #332 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and has held it in 24 quarters since.
  • 215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.